Hookipa Pharma Inc.

04/10/2021 | Press release | Distributed by Public on 04/11/2021 12:30

HOOKIPA announces positive preliminary Phase 1 immunogenicity data for its immunotherapy candidates to treat advanced HPV16+ cancers